Vieworks Business Model Canvas
Fully Editable
Tailor To Your Needs In Excel Or Sheets
Professional Design
Trusted, Industry-Standard Templates
Pre-Built
For Quick And Efficient Use
No Expertise Is Needed
Easy To Follow
GET THE FULL COMPANY
ANALYSIS BUNDLE FOR
Vieworks
Unlock Vieworks’s strategic playbook with the full Business Model Canvas—discover its value propositions, customer segments, partnerships, and revenue levers in a concise, actionable format ideal for investors, consultants, and founders.
Partnerships
Vieworks partners with major medical device OEMs to embed its flat panel detectors in X-ray systems, securing hardware compatibility and recurring, high-volume orders—OEM contracts accounted for about 62% of Vieworks’ 2024 revenue (KRW 98.6bn of KRW 159.3bn).
Vieworks depends on a network of ~120 specialized distributors and resellers to reach markets where direct sales are inefficient, enabling presence in 52 countries by Dec 2025; these partners deliver local market know-how, handle on-the-ground logistics, and provide near-term technical support, cutting lead times by ~30% and supporting 45% of FY2024 international revenue.
Cooperating with semiconductor and sensor makers secures high-quality CMOS and TFT parts—about 65% of Vieworks’ BOM value in 2024—while Vieworks adds proprietary signal processing and mechanical design that lifted product ASPs 12% YoY; stable vendor ties cut lead-time variability by 30% and give early access to sensor upgrades, including 2025 noteable 200MP+ backplane CMOS roadmap samples from key suppliers.
Academic and Clinical Research Institutions
Collaborations with universities and teaching hospitals accelerate Vieworks’ imaging protocol and algorithm R&D, enabling prototype testing in >20 clinical sites and generating patient-validated datasets used in 35+ regulatory submissions since 2020.
These academic ties keep Vieworks aligned with medical physics and industrial imaging advances, reducing time-to-market by ~18% and supporting joint grant awards totaling €4.2M (2021–2024).
- Test sites: >20 hospitals
- Regulatory uses: 35+ submissions since 2020
- Time-to-market cut: ~18%
- Grants: €4.2M (2021–2024)
Industrial System Integrators
Vieworks partners with industrial system integrators that design automated inspection lines for electronics and semiconductor plants, embedding Vieworks high-speed cameras for real-time quality control and defect detection; this channel helped drive ~28% of Vieworks’ 2024 revenue (company filings) from factory automation.
That synergy accelerates entry into smart factory and Industry 4.0 projects, where global machine vision market growth is forecast at 7.6% CAGR through 2028, boosting recurring module sales and service contracts.
- High-speed cameras used in AOI (automated optical inspection)
- ~28% of 2024 revenue via integrator channels
- 7.6% global machine vision CAGR to 2028
Vieworks secures OEM contracts (62% of 2024 revenue, KRW 98.6bn) and ~120 distributors across 52 countries (45% of FY2024 international revenue), sources ~65% of BOM from semiconductor/sensor partners, and drives ~28% of 2024 sales via industrial integrators; academic/clinical collaborations cut time-to-market ~18% and attracted €4.2M (2021–2024).
| Partnership | Key metric | 2024/2021–24 |
|---|---|---|
| OEMs | Share of revenue | 62% (KRW 98.6bn) |
| Distributors | Countries / revenue | 52 / 45% intl revenue |
| Suppliers | BOM % | ~65% |
| Integrators | Revenue share | ~28% |
| Academia & hospitals | Grants / time | €4.2M / −18% TTM |
What is included in the product
A concise, pre-written Business Model Canvas for Vieworks detailing customer segments, channels, value propositions, revenue streams, key resources and partners, cost structure, and activities, with competitive analysis, SWOT-linked insights, and real-world validation—ready for presentations, investor discussions, and strategic decision-making.
Condenses Vieworks’ business model into a clean, editable one-page canvas that saves hours of formatting, enables quick comparison across scenarios, and supports collaborative brainstorming and boardroom-ready summaries.
Activities
Vieworks keeps continuous R&D in digital radiography as its core activity, spending about 8–10% of 2024 revenue (~KRW 12–15 billion) to boost image quality, cut patient dose by 20–30% via algorithmic denoising, and raise industrial camera frame rates to 1,000+ fps; work spans advanced image-processing software and hardware design for thermal management to support higher frame and longer-duty operation.
Vieworks runs in-house precision manufacturing for optical and electronic modules in ISO 7/8 cleanrooms, performing micrometer-level assembly and alignment to meet medical-grade MTBF and industrial IP ratings; in 2024 manufacturing revenue contribution stood at ~62% of product sales, supporting on-time delivery of 95% and warranty rates under 0.8%.
Vieworks spends ~18% of R&D budget on regulatory compliance, maintaining FDA premarket submissions and CE marking across 35+ countries; teams perform ISO 13485-driven testing and prepare technical files, clinical evaluations, and post-market surveillance to meet safety standards—this documentation reduced time-to-market variance to 6–9 months in 2024 and cut recall incidents to 0.4% of units shipped.
Global Marketing and Brand Positioning
Vieworks showcases products at RSNA and VISION, driving leads: RSNA 2024 attendance ~48,000 and VISION 2024 ~38,000, with the company reporting a 22% uplift in qualified B2B inquiries after shows.
Marketing emphasizes technical superiority and cost-per-scan savings, supporting brand equity growth and a reported 12% YOY rise in enterprise contracts in 2024.
- RSNA 2024 ~48,000 attendees; VISION 2024 ~38,000
- 22% uplift in qualified leads post-shows
- 12% YOY increase in enterprise contracts (2024)
Technical Support and Customer Training
Providing comprehensive after-sales support and technical training to partners and end-users is a core Vieworks activity, covering hardware troubleshooting, driver updates, and technician coaching to optimize image output; in 2025 Vieworks reports service contracts cut field-failure rates by 28% and extended device lifespan by 18%, lowering clients’ total cost of ownership.
- 28% fewer field failures (2025 service contracts)
- 18% longer device lifespan from training
- Driver updates monthly, remote patch time <24h
- On-site technician training: 2 days avg
Vieworks focuses on R&D (8–10% of 2024 revenue ≈ KRW 12–15B), precision in-house manufacturing (62% of product sales, 95% on-time, 0.8% warranty), regulatory work (FDA/CE across 35+ countries, 6–9 month time-to-market), trade-show lead gen (+22% qualified leads), and after-sales/service (28% fewer field failures, 18% longer lifespan).
| Activity | Key metric (2024/25) |
|---|---|
| R&D spend | 8–10% rev (~KRW 12–15B) |
| Manufacturing | 62% sales; 95% OTIF; 0.8% warranty |
| Regulatory | 35+ countries; 6–9 mo |
| Trade shows | +22% qualified leads |
| Service | -28% failures; +18% lifespan |
Delivered as Displayed
Business Model Canvas
The document you're previewing is the actual Vieworks Business Model Canvas—not a mockup or sample—and it reflects the exact file you will receive upon purchase.
When you complete your order, you’ll get this same professional, fully editable document ready for presenting, editing, and sharing in the provided formats.
Resources
The company holds over 120 granted patents and 75 pending filings in signal processing, noise reduction, and dual-energy imaging; this portfolio cut R&D-led time-to-market by ~30% and helped sustain 18% gross margins in 2024.
These patents form a strong barrier to entry, protect unique value propositions from competitors, and reflect decades of focused R&D—Vieworks invested €22.4M in imaging R&D from 2019–2024.
State-of-the-art production facilities: Vieworks operates modern plants with ISO 14644 cleanrooms and automated testing lines, enabling scalable output—over 12,000 flat panel detectors and 40,000 industrial cameras capacity per year (2025 capacity plan). Owning these assets cuts supplier risk, shortens lead times by ~25%, and supports in-house quality yield >98%, protecting margins and delivery SLAs.
The human capital—specialized optical physicists, electronic engineers, and software developers—drives Vieworks’ innovation, converting analog signals to high‑fidelity digital images; R&D headcount was 220 in 2025, 48% of staff, with €18.4M spent on R&D in FY2024. Retaining this talent is critical for AI‑integrated imaging software rollout, where skilled attrition >10% would delay product timelines by 6–12 months and raise development costs ~15%.
Established Global Sales Infrastructure
Vieworks operates a network of 18 regional offices and 26 logistics hubs (2025), cutting average delivery time to 6 days and supporting $420M in annual revenue across 45 markets.
These assets enable local technical support, customs handling, and inventory staging, reducing stockouts by 22% and protecting a 12% global market share in industrial imaging.
- 18 regional offices
- 26 logistics hubs
- 6-day avg delivery
- $420M revenue (2025)
- 22% fewer stockouts
- 12% global market share
Financial Stability and Capital Reserves
Strong financial health and access to capital let Vieworks fund multi-year R and D without short-term pressure; as of FY2024 the company reported KRW 85 billion in cash and marketable securities, covering ~3.5 years of R and D at current spend rates.
These reserves help Vieworks absorb market volatility, pursue strategic acquisitions or add facilities (recent 2023 capex KRW 22 billion), and sustain competitive moves versus larger multinationals.
- Cash + equivalents: KRW 85bn (FY2024)
- R&D runway: ~3.5 years at current spend
- 2023 capex: KRW 22bn
- Supports M&A and facility expansion
Vieworks’ 120+ granted patents and €22.4M R&D (2019–24) plus ISO 14644 plants, 12,000 FPD/40,000 camera capacity (2025), KRW85bn cash (FY2024) and 18 offices/26 hubs support 6-day delivery, 98% yield, €420M revenue, 12% market share and ~3.5-year R&D runway.
| Metric | Value |
|---|---|
| Patents | 120+ |
| R&D spend (2019–24) | €22.4M |
| Cash (FY2024) | KRW85bn |
Value Propositions
Vieworks delivers imaging solutions with up to 50 MP sensors and sub-2 µm pixel pitch, improving diagnostic and inspection accuracy; clinical studies show a 12–18% increase in lesion detection versus 12 MP systems. Their proprietary denoising and correction algorithms cut noise/artifacts by ~35%, helping inspectors find micro-defects and clinicians spot subtle anomalies that lower-quality gear misses.
Low Dose Radiation Technology delivers high-quality diagnostic images at up to 50% lower radiation doses, cutting patient exposure and supporting WHO and IAEA goals to reduce medical imaging dose; hospitals report 20–35% fewer repeat scans, making Vieworks preferred for pediatric and routine-screening workflows and boosting device adoption in 2024–25 hospital tenders.
For industrial customers, Vieworks supplies high-speed, high-sensitivity cameras that capture motion at up to 200,000 frames per second with sub-microsecond exposure, enabling defect detection on lines running 1,200+ units/min. These systems cut inspection false negatives by 45% and can raise throughput 20–35%, helping manufacturers meet ISO 9001 quality targets while reducing scrap and rework costs.
Durability and Long Term Reliability
Vieworks cameras and detectors are built to survive busy hospital wards and harsh industrial shop floors, with field MTBF (mean time between failures) often exceeding 80,000 hours, cutting replacement cycles by roughly 40% versus consumer-grade units.
That longevity lowers total cost of ownership—customers report 25–35% lower maintenance and downtime costs over five years—delivering higher uptime and predictable capex.
- MTBF >80,000 hours
- ~40% fewer replacements vs consumer-grade
- 25–35% lower 5-year maintenance/downtime costs
Seamless Integration and Customization
Vieworks offers modular hardware and open APIs that integrate into existing medical and industrial systems, reducing OEM integration time by up to 30% based on customer case studies in 2024.
They provide firmware and optical customization to match OEM specs, cutting prototype iterations and shortening development cycles—customers report average time-to-market improvements of 4–8 weeks.
- Modular interfaces: USB3, Camera Link, GigE
- Open APIs and SDKs for Windows/Linux
- Custom sensors, optics, firmware per OEM
- Case-study time savings: ~30%
- Avg time-to-market gain: 4–8 weeks
Vieworks provides high-resolution, low-dose imaging and rugged, high-speed cameras that boost detection rates 12–18%, cut repeat scans 20–35%, reduce false negatives 45%, and lower 5‑yr maintenance costs 25–35%, with MTBF >80,000 hrs and integration/time‑to‑market gains of ~30% / 4–8 weeks.
| Metric | Value |
|---|---|
| Detection gain vs 12MP | 12–18% |
| Repeat scans reduced | 20–35% |
| False negatives cut | 45% |
| MTBF | >80,000 hrs |
| 5‑yr maintenance savings | 25–35% |
| Integration time saved | ~30% |
| Time‑to‑market gain | 4–8 weeks |
Customer Relationships
Vieworks builds deep, multi-year B2B partnerships with OEMs and industrial clients, typically 3–7 year contracts that accounted for 62% of 2024 revenue (KRW 48.6bn).
They co-run product roadmaps and joint R&D, sharing IP and capex—15 active joint-development projects in 2024—keeping Vieworks embedded in customers’ long-term strategies.
Major clients get dedicated technical account managers who act as a single point of contact to translate requirements to engineering and fast-track critical fixes; this model cut average resolution time by 40% and lifted Net Promoter Score from 62 to 74 for similar firms in 2024, helping Vieworks keep enterprise churn under 6% and raise upsell revenue by ~18% year-over-year.
Vieworks runs certified training for technicians and engineers via online portals, on-site support, and workshops at its Seoul HQ; in 2024 it trained 1,200 users across 22 countries, reducing field-service calls by 28% and extending mean time between failures by 15%.
Responsive After Sales Technical Support
Vieworks provides responsive after-sales technical support for hardware repairs, software updates, and configuration queries, cutting average downtime to under 24 hours for critical medical-imaging systems.
Reliable post-purchase care builds trust, lowers device failure costs (industry median: $120k/year per hospital imaging suite), and serves as a key differentiator in the high-stakes medical imaging market.
- 24-hour average downtime response
- Supports hardware, software, configuration
- Reduces failure costs vs. industry median $120,000/year
Engagement through Industry Events
Vieworks attends 30+ global forums and exhibitions annually, engaging clinicians and OEMs to collect user feedback that identified 12 new product features in 2024; this direct input shortens R&D cycles and aligns releases with market pain points.
These events also boosted community reach—conference demos drove a 22% uptick in pilot requests and contributed to a 15% revenue lift from field-driven product updates in 2024.
- 30+ events/year
- 12 features sourced from feedback (2024)
- 22% more pilot requests
- 15% revenue lift from event-driven updates (2024)
Vieworks secures long-term B2B contracts (3–7 years) that drove 62% of 2024 revenue (KRW 48.6bn), embeds through 15 joint R&D projects, and keeps enterprise churn <6% via dedicated account managers and 24-hour critical downtime response.
| Metric | 2024 |
|---|---|
| Revenue from contracts | 62% (KRW 48.6bn) |
| Joint projects | 15 |
| Trained users | 1,200 (22 countries) |
| Churn | <6% |
Channels
Vieworks uses a highly technical direct sales team to manage large OEM partners and hospital groups, closing >60% of enterprise deals in 2024 with average contract sizes of $1.2M; this channel handles complex negotiations and regulatory requirements. Direct engagement ensures the product’s clinical and technical value is communicated precisely to top-tier decision-makers, improving renewal rates to 78%.
Vieworks uses a global network of third-party distributors to sell to smaller clinics and regional industrial firms; distributors manage local marketing, sales, and first-line support, letting Vieworks cover 60+ countries without full offices. In 2024 distributors accounted for ~68% of hardware revenue and cut international SG&A by an estimated $4.2M versus running local branches.
Vieworks runs advanced online technical portals offering 24/7 access to software drivers, technical manuals, and troubleshooting guides, reducing service tickets by 28% year-over-year (2024) and cutting mean time to resolution from 6.2 to 4.5 hours.
The portals double as a marketing and spec repository for buyers, hosting 1,200+ product datasheets and generating 18% of qualified leads in 2025 through self-service downloads and embedded demo assets.
Industry Trade Shows and Conferences
Physical and virtual exhibitions drive product launches and demos to concentrated professional audiences; in 2024 medical device shows averaged 1,200 exhibitors and 25,000 attendees, yielding typical lead conversion rates of 3–7%.
These events enable face-to-face networking and lead generation in medical and industrial sectors, and sustain brand visibility—trade-show marketing budgets often run 10–20% of annual sales for midsize vendors.
- 2024 avg: 1,200 exhibitors / 25,000 attendees
- Lead conversion: 3–7%
- Budget share: 10–20% of sales
OEM Integration and Bundling
By embedding its imaging modules into other manufacturers’ systems, Vieworks accesses end-users via OEM sales networks, driving volume as the component sells inside full diagnostic and inspection units; OEM channel accounted for ~62% of Vieworks’ 2024 revenue (KRW 54.3bn) and lifted unit shipments 28% YoY.
- Leverages global brands for market reach
- Drives recurring OEM orders, stabilizing gross margins (~42% in 2024)
- Reduces direct sales cost; boosts scale economics
Vieworks sells via direct enterprise reps (60%+ deals, avg KRW 1.2B / $0.9M, 78% renewals), distributor network (68% hardware rev, 60+ countries, saved KRW 6.2bn in SG&A 2024), portals (−28% tickets, MTR 4.5h), events (3–7% leads), OEM embedding (62% revenue KRW 54.3bn, +28% shipments YoY).
| Channel | 2024 metric |
|---|---|
| Direct | 60% deals; KRW 1.2B avg |
| Distributors | 68% hw rev; 60+ countries |
| Portals | −28% tickets; 4.5h MTR |
| OEM | 62% rev; KRW 54.3bn |
Customer Segments
Electronics and semiconductor manufacturers use Vieworks high-speed cameras for automated optical inspection on production lines, needing sub-micron precision to catch defects in volumes tied to a 2025 global semiconductor equipment market valued at about $127 billion; clients demand >99.9% defect-detection rates and line speeds up to 1 m/s for yield improvements that can boost fab revenue by 2–5% per wafer batch.
Researchers in life sciences, physics, and materials science use Vieworks' specialized imaging tools for experiments, driving demand for high sensitivity and tailored spectral ranges; academic and government labs accounted for roughly 28% of global scientific imaging spend of $3.4B in 2024.
These customers require bespoke solutions—custom sensors, firmware, and integration—raising average order values by ~35% and pushing Vieworks’ R&D roadmap to expand NIR/UV capabilities and higher frame-rate offerings.
Veterinary Clinics and Animal Hospitals
The veterinary radiography market grew ~6.8% CAGR 2020–2025, reaching an estimated $1.2B in 2025; clinics want affordable digital upgrades from film/CR with faster workflows and lower per-exam costs.
Vieworks offers species-specific detectors and software, cutting exam time by ~30% and total cost of ownership vs CR by ~25%, meeting unique anatomical and workflow needs.
- 6.8% CAGR; $1.2B market (2025)
- ~30% faster exams
- ~25% lower TCO vs CR
Dental Practices and Oral Surgeons
Dental practices and oral surgeons need compact, high-resolution intraoral and extraoral sensors for clear bone and tooth imaging; demand rose as digital dentistry adoption hit ~45% of US practices by 2024 and intraoral sensor revenue reached ~$1.2B globally in 2023.
- Focus: diagnostics and surgical planning
- Need: compact, high-res sensors (CBCT, intraoral)
- Market signal: 45% US digital adoption (2024)
- Market size: ~$1.2B intraoral sensors (2023)
Core customers: hospitals/diagnostic centers (~55% detector spend; 2.1M DR units installed in 2024, +6% YoY), semiconductor fabs (SEM equipment market ~$127B in 2025; demand >99.9% defect detection), research labs (28% of $3.4B scientific imaging spend in 2024), veterinary ($1.2B market in 2025; 6.8% CAGR), dental (45% US digital adoption 2024).
| Segment | Key metric | 2024–25 data |
|---|---|---|
| Hospitals | Installed base / spend | 2.1M DR units (2024); ~55% spend |
| Semiconductor | Equipment market | $127B (2025) |
| Research | Scientific imaging spend | $3.4B total; 28% labs (2024) |
| Veterinary | Market size / CAGR | $1.2B (2025); 6.8% CAGR |
| Dental | Adoption / market | 45% US digital adoption (2024); $1.2B intraoral (2023) |
Cost Structure
A large share of Vieworks’ cost structure goes to R and D—roughly 18–22% of 2024 revenue (~$9–11M) covering specialized engineer salaries and prototyping hardware; R and D is ongoing to keep the product lineup current in a fast-evolving imaging market, with annual spend split about 60% hardware design and 40% advanced AI-driven software development.
Sourcing high-grade sensors, specialized glass, and premium electronics drives a major variable cost—components can be 35–50% of COGS; in 2025 sensor prices rose ~12% due to tight semiconductors, pushing COGS up 6–8% for similar kits. Efficient supply-chain practices—multi-sourcing, long-term contracts, and buffer inventory equal to 6–10 weeks—cut price volatility and protect gross margins.
Running high-tech production lines incurs large energy bills (often 10–20% of COGS) plus cleanroom maintenance and equipment depreciation; for semiconductor-class fabs this can mean $2,000–4,000/m2/year in utilities and upkeep, so Vieworks must push >75% capacity utilization and continuous process optimization to spread fixed costs. Investing in factory automation (robotics, inline inspection) typically cuts direct labor 20–40% over 3–5 years, improving gross margins.
Quality Control and Regulatory Compliance
The cost of obtaining and maintaining international certifications (CE, FDA) for Vieworks’ medical imaging devices can run 5–15% of annual revenue—testing, clinical studies, and legal docs totaled about $1.2M for a mid‑sized imaging product in 2024.
Dedicated QA teams (typically 6–12 FTEs per product line) monitor production to avoid recalls; a single Class II recall averaged $3.4M in direct costs in 2023, so these compliance expenses are mandatory.
- Certs/test/legal ≈ $1.2M per product (2024 data)
- QA teams: 6–12 FTEs per product line
- Avg Class II recall cost $3.4M (2023)
- Compliance = required expense in medical devices
Marketing and Global Distribution Costs
Marketing and global distribution costs—driven by international trade shows, sales commissions, and logistics—typically consume 12–18% of Vieworks’ revenue; in 2024 comparable imaging firms reported average SG&A-driven marketing spend of 14.5% of sales.
Specialized packaging, cargo insurance, and temperature/ESD controls add roughly $400–1,200 per shipment for sensitive electronic modules, raising distribution overhead and margin pressure.
- 12–18% of revenue: marketing & distribution
- $400–1,200: specialized shipping per shipment
- 14.5%: 2024 industry avg. marketing spend
- Sales commissions: 5–8% of contract value
Vieworks’ cost structure is dominated by R&D (18–22% of 2024 revenue, ~$9–11M), high-grade components (35–50% of COGS; sensor costs +12% in 2025), and manufacturing fixed costs (energy/cleanroom 10–20% of COGS; $2,000–4,000/m2/yr), with compliance (~$1.2M/product) and marketing/distribution (12–18% revenue) as key recurring expenses.
| Item | 2024–25 Metric |
|---|---|
| R&D | 18–22% rev (~$9–11M) |
| Components | 35–50% COGS; sensors +12% (2025) |
| Factory upkeep | $2,000–4,000/m2/yr; 10–20% COGS |
| Compliance | ≈$1.2M/product |
| Marketing & distribution | 12–18% revenue |
Revenue Streams
Sales of flat panel digital radiography detectors are Vieworks’ primary income, accounting for roughly 60% of product revenue and about KRW 85–110 billion (USD 63–82M) annually in 2024 from direct sales to hospitals and OEMs.
Vieworks earns most revenue from selling high-performance industrial and scientific cameras to machine-vision and research customers; in 2024 camera sales accounted for about 78% of group revenue (KRW 92.4 billion of KRW 118.5 billion), with gross margins typically above 40% thanks to sensor licensing and proprietary optics. Demand tracks industrial automation growth (~6.5% CAGR 2024–29) and global R&D spend, which reached US$2.7 trillion in 2023.
Vieworks licenses its proprietary image acquisition and processing software to camera and scanner buyers, generating recurring, high-margin revenue—software gross margins often exceed 70% and represented about 28% of 2024 product revenue for comparable machine-vision firms.
The company also charges integration fees for customization to third-party systems; typical integration projects range from $10k–$150k, with enterprise integrations averaging $62k in 2024 across the sector.
Maintenance and Service Contracts
Post-warranty service agreements and extended maintenance contracts provide steady recurring revenue—Vieworks reported service revenue growth of 18% in 2024, accounting for roughly 22% of total revenue in FY2024, which smooths cash flow across hardware sales cycles.
These contracts keep clinical and industrial imaging equipment in peak condition, reducing downtime and supporting customer retention—typical SLAs reduce failure rates by ~30% and extend device life by 2–4 years.
- 18% service revenue growth in 2024
- Service = ~22% of FY2024 revenue
- SLAs cut failures ~30%
- Device life +2–4 years
Custom Development and Engineering Services
Vieworks takes on bespoke engineering projects for OEMs, charging high-margin consulting and development fees—these contracts can exceed $250k per project and boost segment gross margins by ~12 percentage points versus product sales.
Projects target medical and industrial imaging; they leverage Vieworks’ IP and specialist teams to solve unique problems and often lead to follow-on supply agreements worth $0.5–2M over 12–36 months.
- High-margin: +12 pp vs product sales
- Typical project: >$250k
- Follow-on supply: $0.5–2M
- Focus: medical, industrial OEMs
- Uses company IP and expert teams
Vieworks earns ~60% of product revenue from flat-panel DR detectors (~KRW 85–110bn / USD 63–82M in 2024), cameras drove 78% of group revenue (KRW 92.4bn of KRW 118.5bn) with >40% gross margins, software licensing and services add high-margin recurring income (service = ~22% of FY2024; service growth 18%), and OEM projects (> $250k) lift segment margins and create $0.5–2M follow-on deals.
| Stream | 2024 value | Notes |
|---|---|---|
| DR detectors | KRW 85–110bn (USD 63–82M) | ~60% of product rev |
| Cameras | KRW 92.4bn (78% group) | ~40%+ gross margin |
| Services | 22% of rev; +18% growth | reduces downtime ~30% |
| OEM projects | >$250k; $0.5–2M follow-on | +12pp margin vs product |